Urology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kedia GT et al. - The results have provide additional evidence that the function of prostatic smooth muscle is under the control of peptidergic and cyclic nucleotide (cyclic guanosine monophosphate, cyclic adenosine monophosphate)-mediated pathways. This might give a rationale for the use of drugs interacting with cyclic guanosine monophosphate or cyclic adenosine monophosphate signaling, such as PDE inhibitors or nitric oxide donors, in the pharmacotherapy of the benign prostatic syndrome.

Today in Basic Science/Genetics...keeping you current

Mapping of a new locus for congenital anomalies of the kidney and urinary tract on chromosome 8q24
Nephrology Dialysis Transplantation, 12/14/09

DD3PCA3 gene expression in cancer and prostatic hyperplasia
Clinical and Investigative Medicine, 12/14/09

Deletion of the CUL4B gene in a boy with mental retardation, minor facial anomalies, short stature, hypogonadism, and ataxia
American Journal of Medical Genetics, 12/14/09

Today in Prostate...keeping you current

Prediction of PSA bounce after permanent prostate brachytherapy for localized prostate cancer
International Journal of Clinical Oncology, 12/15/09

Prostatic Ductal Adenocarcinoma: A Mini Review
Medical Principles and Practice, 12/15/09

Prostate-Specific Antigen, Prostate Cancer, and Disorders of Hemostasis
Seminars in Thrombosis and Hemostasis, 12/14/09